# SUNITINIB MALATE
> **ANDA218012** · Abbreviated New Drug Application (Generic) · Sponsor: FOSUN WANBANG · Approved 2023-08-21
## Drug
- **FDA Application Number:** ANDA218012
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SUNITINIB MALATE
- **Generic name:** SUNITINIB MALATE
- **Active ingredients:** SUNITINIB MALATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** FOSUN WANBANG
- **Manufacturer:** Novugen Pharma (USA) LLC.
- **First approval:** 2023-08-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218012)
---
*MORVS · CC0 1.0*